Anaplastic thyroid cancer: current capabilities of an oncologist
Continuous development of oncology as a science in the last decades and years led to noticeable improvement in treatment outcomes for patients with various malignant tumors. Diagnostics, surgery, radiotherapy significantly contributed to this improvement, however they cannot be compared to the progr...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-06-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850024058252427264 |
|---|---|
| author | A. L. Pylev D. S. Romanov N. V. Lasunin D. A. Balaeva M. P. Kazakov |
| author_facet | A. L. Pylev D. S. Romanov N. V. Lasunin D. A. Balaeva M. P. Kazakov |
| author_sort | A. L. Pylev |
| collection | DOAJ |
| description | Continuous development of oncology as a science in the last decades and years led to noticeable improvement in treatment outcomes for patients with various malignant tumors. Diagnostics, surgery, radiotherapy significantly contributed to this improvement, however they cannot be compared to the progress achieved through advancements in our knowledge of genetic structure of tumors and subsequent advancements in pharmacology which allowed to achieve qualitatively better survival in oncological patients. These advancements did not leave out such a serious and highly lethal, though fortunately rare, disease as anaplastic thyroid cancer. This article is dedicated to the possibilities of using checkpoint inhibitors in treatment of this pathology to increase expected life span of the patients. |
| format | Article |
| id | doaj-art-687531793fc647c39c141d1d268bfa89 |
| institution | DOAJ |
| issn | 2222-1468 2411-4634 |
| language | Russian |
| publishDate | 2023-06-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли головы и шеи |
| spelling | doaj-art-687531793fc647c39c141d1d268bfa892025-08-20T03:01:13ZrusABV-pressОпухоли головы и шеи2222-14682411-46342023-06-0113111612510.17650/2222-1468-2023-13-1-116-125544Anaplastic thyroid cancer: current capabilities of an oncologistA. L. Pylev0D. S. Romanov1N. V. Lasunin2D. A. Balaeva3M. P. Kazakov4Center for Innovative Medical TechnologiesCenter for Innovative Medical Technologies; Central Clinical Hospital of Russian Railways-Medicine; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaN.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of RussiaCentral Clinical Hospital of Russian Railways-Medicine; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaCenter for Innovative Medical TechnologiesContinuous development of oncology as a science in the last decades and years led to noticeable improvement in treatment outcomes for patients with various malignant tumors. Diagnostics, surgery, radiotherapy significantly contributed to this improvement, however they cannot be compared to the progress achieved through advancements in our knowledge of genetic structure of tumors and subsequent advancements in pharmacology which allowed to achieve qualitatively better survival in oncological patients. These advancements did not leave out such a serious and highly lethal, though fortunately rare, disease as anaplastic thyroid cancer. This article is dedicated to the possibilities of using checkpoint inhibitors in treatment of this pathology to increase expected life span of the patients.https://ogsh.abvpress.ru/jour/article/view/874anaplastic thyroid cancercheckpoint inhibitorspembrolizumabmetastatic brain damage |
| spellingShingle | A. L. Pylev D. S. Romanov N. V. Lasunin D. A. Balaeva M. P. Kazakov Anaplastic thyroid cancer: current capabilities of an oncologist Опухоли головы и шеи anaplastic thyroid cancer checkpoint inhibitors pembrolizumab metastatic brain damage |
| title | Anaplastic thyroid cancer: current capabilities of an oncologist |
| title_full | Anaplastic thyroid cancer: current capabilities of an oncologist |
| title_fullStr | Anaplastic thyroid cancer: current capabilities of an oncologist |
| title_full_unstemmed | Anaplastic thyroid cancer: current capabilities of an oncologist |
| title_short | Anaplastic thyroid cancer: current capabilities of an oncologist |
| title_sort | anaplastic thyroid cancer current capabilities of an oncologist |
| topic | anaplastic thyroid cancer checkpoint inhibitors pembrolizumab metastatic brain damage |
| url | https://ogsh.abvpress.ru/jour/article/view/874 |
| work_keys_str_mv | AT alpylev anaplasticthyroidcancercurrentcapabilitiesofanoncologist AT dsromanov anaplasticthyroidcancercurrentcapabilitiesofanoncologist AT nvlasunin anaplasticthyroidcancercurrentcapabilitiesofanoncologist AT dabalaeva anaplasticthyroidcancercurrentcapabilitiesofanoncologist AT mpkazakov anaplasticthyroidcancercurrentcapabilitiesofanoncologist |